# FDA Inspection 1153864 - AmeriPac, Inc - August 27, 2021

Source: https://www.keypedia.com/records/fda_inspections/ameripac-inc/bffa56f0-d2d0-44a2-8a38-fb76f78a0b00
Source feed: FDA_Inspections

> FDA Inspection 1153864 for AmeriPac, Inc on August 27, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1153864
- Company Name: AmeriPac, Inc
- Inspection Date: 2021-08-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 948406 - 2015-11-06](https://www.keypedia.com/records/fda_inspections/ameripac-inc/9703bf41-5a0c-4e20-b463-3502d4ef5a35)
- [FDA Inspection 696894 - 2010-11-09](https://www.keypedia.com/records/fda_inspections/ameripac-inc/71d14f5c-cb49-4812-b995-b2822a4d8f85)

Company: https://www.keypedia.com/companies/ameripac-inc/e706d9d7-b3a9-4548-b2cd-8446f27b0cd1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c